A Randomized Single Center Double Blind 2 Period Crossover Glucose Clamp Study to Test for Bioequivalence Between 2 Recombinant Human Isophane Insulins Wockhardt's Human Isophane Insulin Injection100IU/ml With Novolin N in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 26 Dec 2012
At a glance
- Drugs Insulin suspension isophane (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Wockhardt
- 26 Apr 2011 Planned end date changed from 1 Feb 2009 to 1 Apr 2011 as reported by ClinicalTrials.gov.
- 26 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Oct 2008 New trial record.